26 August 2022

How to do Compliance Risk Analysis

The German Federal Office of Economy and Export Control (BAFA) published on August 17, 2022 a manual for conducting risk analyses according to of the new German Act on Corporate Due Diligence Obligations in Supply Chains.

Our GSK Update summarizes this important guidance by the competent regulatory authority and comments on the central role of conducting appropriate compliance risk analysis for every corporate compliance management effort.

Print


Press contact
presse@gsk.de
+49 30 203907-7763

Back

GSK Updates
  • 23 November 2022

    GSK Update: FAQs on the most important PRIIP requirements as of 01.01.2023

    Read more
  • 06 October 2022

    GSK Update: Real estate transfer tax on share deals – how to approach potential double taxation issues

    Read more
  • 26 August 2022

    GSK Update: How to do Compliance Risk Analysis

    Read more
Contact person

Eric Mayer

Local Partner*

+49 89 288174-73

eric.mayer@gsk.de

For reasons of better readability, we use the gender-neutral generic masculine. However, the information expressly refers to all genders.

CO2 Neutral